Intervention

Conventional Surgery

ClinicalTrials.gov intervention label

Clinical trials5
Recruiting0
Common conditions25
Lead sponsors shown3

Clinical trials

5 shown
Bronchoscopic Laser Ablation of Peripheral Lung TumorsNCT03707925 · 2018-09-18
TERMINATED
Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFRNCT02720185 · 2017-05-03
TERMINATED
Prospective Analysis of Robot-Assisted SurgeryNCT02292914 · 2014-03-10
UNKNOWN
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast CancerNCT01334021 · 2011-05-31
ACTIVE_NOT_RECRUITING
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerNCT00002855 · 1996-08-01
COMPLETED

Common conditions

Prostate Cancer2Anatomic Stage I Breast Cancer AJCC v81Anatomic Stage IA Breast Cancer AJCC v81Anatomic Stage IB Breast Cancer AJCC v81Anatomic Stage II Breast Cancer AJCC v81Anatomic Stage IIA Breast Cancer AJCC v81Anatomic Stage IIB Breast Cancer AJCC v81Anatomic Stage III Breast Cancer AJCC v81Anatomic Stage IIIA Breast Cancer AJCC v81Anatomic Stage IIIB Breast Cancer AJCC v81Anatomic Stage IIIC Breast Cancer AJCC v81Anatomic Stage IV Breast Cancer AJCC v81Bladder Cancer1Breast Neoplasms1Esophageal Cancer1Gastric Cancer1Head and Neck Cancer1Invasive Breast Carcinoma1Lung Cancer1Lung Carcinoid Tumor1Lung Non-Small Cell Carcinoma1Metastatic Lung Carcinoma1Pancreatic Cancer1Prognostic Stage I Breast Cancer AJCC v81Prognostic Stage IA Breast Cancer AJCC v81

Trial status mix

TERMINATED2
ACTIVE_NOT_RECRUITING1
COMPLETED1
UNKNOWN1

Phase mix

NA2
PHASE22
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.